In fact, in preclinical models, CRC cell lines with KRAS, BRAF, NRAS, and PIK3CA wild-type status developed resistance to cetuximab and panitumumab when ectopic cMET overexpression was induced by cDNA transfection. Here, KRAS is linked to colorectal carcinoma.